These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4190580)

  • 1. G.-6-P.D. deficiency and Down's syndrome.
    Cao A; Falorni A; De Virgiliis S
    Lancet; 1970 Mar; 1(7647):621. PubMed ID: 4190580
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome.
    Sutnick AI; Oski FA; London WT; Millman I; Blumberg BS
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):3-8. PubMed ID: 4257700
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrocyte ATP: D-fructose-6-phosphate 1-phosphotransferase (phosphofructokinase) activity in children with normałG trisomic mosaic Down's syndrome and in normal and Down's syndrome controls.
    Benson PF; Linacre B; Taylor AI
    Nature; 1968 Dec; 220(5173):1235-6. PubMed ID: 4302265
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrocyte enzymes in Down's syndrome.
    Rosner F
    Lancet; 1970 May; 1(7653):951. PubMed ID: 4191575
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrocyte enzymes in Down's syndrome.
    Cao A; Falorni A; De Virgiliis S
    Lancet; 1970 May; 1(7653):951. PubMed ID: 4191576
    [No Abstract]   [Full Text] [Related]  

  • 6. Leucocyte alkaline phosphatase and erythrocyte glucose-6-phosphate dehydrogenase in Down's Syndrome.
    Phillips J; Herring RM; Goodman HO; King JS
    J Med Genet; 1967 Dec; 4(4):268-73. PubMed ID: 4230173
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythrocyte enzymes and substrates in children with Down's syndrome].
    Schwarzmeier JD; Rett A; Moser K; Andrle M
    Wien Klin Wochenschr; 1973 Jan; 85(3):33-5. PubMed ID: 4345784
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet-phosphohexokinase levels in Down's syndrome.
    Doery JC; Hirsh J; Garson OM; de Gruchy GC
    Lancet; 1968 Oct; 2(7574):894-5. PubMed ID: 4176151
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal impairment in urate excretion in patients with Down's syndrome.
    Nishida Y; Akaoka I; Kobayashi M; Maruki K; Oshima Y
    J Rheumatol; 1979; 6(1):103-7. PubMed ID: 155745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymes in Down's syndrome.
    Bartels H; Kruse K; Tolksdorf M
    Lancet; 1968 Apr; 1(7546):820. PubMed ID: 4171161
    [No Abstract]   [Full Text] [Related]  

  • 11. Catechol-O-methyltransferase activity in erythrocytes in Down's syndrome.
    Gustavson KH; Wetterberg L; Bäckström M; Ross SB
    Clin Genet; 1973; 4(3):279-80. PubMed ID: 4271829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glutamic-oxaloacetic transaminase in the erythrocytes and lymphocytes of subjects with Down's syndrome].
    Tangheroni W; Cao A; Lungarotti S; Trabalza N; Furbetta M; Coppa G
    Boll Soc Ital Biol Sper; 1971 Jul; 47(13):376-8. PubMed ID: 4257265
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent studies on erythrocyte enzymes in Down's syndrome: GOT isoenzymes].
    Furbetta M; Trabalza N; Cao A; Marcucci F
    Boll Soc Ital Biol Sper; 1971 Nov; 47(21):689-91. PubMed ID: 4260025
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dosage effect of the cytoplasmic superoxide dismutase (SOD-1) gene in the erythrocytes of Down's syndrome patients].
    Tamarkina AD; Annenkov GA; Filippov IK; Lamchingiĭn T
    Genetika; 1977; 13(5):929-32. PubMed ID: 147797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of matrix metalloproteinase (MMP)-2 activity in gingival tissue and cultured fibroblasts from Down's syndrome patients.
    Komatsu T; Kubota E; Sakai N
    Oral Dis; 2001 Jan; 7(1):47-55. PubMed ID: 11354922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythrocytic acid phosphatase isoenzyme patterns in Down's syndrome (author's transl)].
    Mato JM; Sordo MT; Serrano Rios M
    Sangre (Barc); 1975; 20(1):29-32. PubMed ID: 123660
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and concentration of 5-phosphoribosyl-1-pyrophosphate in erythrocytes from patients with Down's syndrome.
    Nishida Y; Akaoka I; Nishizawa T; Maruki M; Maruki K
    Ann Rheum Dis; 1977 Jun; 36(3):261-3. PubMed ID: 141914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemolytic jaundice due to insufficiency of glucose-6-phosphate dehydrogenase in erythrocytes].
    Khitrik GM; Kovalev IuP; Mirvis AB
    Pediatriia; 1969 May; 48(5):10-4. PubMed ID: 5809912
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biomedical study of Down's syndrome].
    Nakamura T
    Nihon Shonika Gakkai Zasshi; 1970 Mar; 74(3):400-11. PubMed ID: 4192691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.